TOPOTECAN/IFOSFAMIDE THERAPY FOR RELAPSED/REFRACTORY PEDIATRIC SOLID TUMORS

被引：0
|
作者：
Sugiyama, Masanaka [1 ]
Arakawa, Ayumu [1 ,2 ]
Watanabe, Yuko [1 ]
Nakajima, Miho [1 ]
Tanimura, Kazuki [1 ]
Uchida, Eriko [1 ]
Tao, Kayoko [1 ]
Yoneda, Akihiro [3 ]
Kawai, Akira [4 ]
Ogawa, Chitose [1 ,2 ]
机构：
[1] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Rare Canc Ctr, Tokyo, Japan
[3] Natl Canc Ctr, Dept Pediat Surg Oncol, Tokyo, Japan
[4] Natl Canc Ctr, Dept Musculoskeletal Oncol & Rehabil, Tokyo, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS7-5
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] Double akylating agents treatment with ifosfamide (IFOS) and cyclophosphamide (CYCLO) for relapsed pediatric solid tumors
    Epelman, Sidnei
    Gorender, Ethel
    Beaugrand, Annick
    Melaragno, Renato
    Meirelles, Priscila
    Oliveira, Renato Guedes
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] DOUBLE ALKYLATING AGENTS TREATMENT WITH IFOSFAMIDE (IFOS) AND CYCLOPHOSPHAMIDE (CYCLO) FOR RELAPSED PEDIATRIC SOLID TUMORS
    Epelman, Sidnei
    Gorender, Ethel
    Beaugrand, Annick
    Meirelles, Priscilla
    Oliveira, Renato
    Melaragno, Renato
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1093 - 1093
  • [23] Precision medicine in relapsed or refractory pediatric solid tumors: a collaborative Spanish initiative
    Pablo Gargallo
    Jaime Font de Mora
    Pablo Berlanga
    Inés Calabria
    Margarita Llavador
    Laia Pedrola
    Joaquín Panadero
    Sandra Dolz
    Ángel Zúñiga
    Juan Silvestre Oltra
    Paloma Escobar
    Yania Yáñez
    María José Aparisi
    Marina Martinez-Matilla
    Vanessa Segura
    Carlos Esquembre
    María Del Cañizo
    María José Moreno
    Catalina Márquez
    Adela Cañete
    Victoria Castel
    Translational Medicine Communications, 4 (1)
  • [24] Pilot study of the novel chemotherapy regimen of topotecan, ifosfamide, and carboplatin (TIC) in children with refractory/recurrent solid tumors.
    Lee, A.
    Handler, C.
    Harrison, L.
    Shen, W. V.
    Gates, L.
    Wells, R. J.
    Wolff, J. E.
    Garvin, J. H.
    Yamashiro, D.
    Cairo, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Impact of breaks in therapy on survival for pediatric patients with relapsed or refractory solid tumors: A single-center study
    McEvoy, Matthew T.
    Seashore, Elizabeth L.
    Smith, Valeria
    Cheng, W. Susan
    Clay, Shondra
    Casas, Jessica
    Foster, Jennie Haunani
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] A Novel Trial of Topotecan, Ifosfamide, and Carboplatin (TIC) in Children With Recurrent Solid Tumors
    Radhakrishnan, Kavita
    Lee, Alice
    Harrison, Lauren A.
    Morris, Erin
    Shen, Violet
    Gates, Laura
    Wells, Robert J.
    Wolff, Johannes E.
    Garvin, James H.
    Cairo, Mitchell S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 274 - 278
  • [27] A Phase 1 Trial of Olaratumab as Monotherapy and in Combination with Doxorubicin, Vincristine/Irinotecan, or High-Dose Ifosfamide in Pediatric Patients with Relapsed/Refractory Solid Tumors
    Mascarenhas, L.
    Ogawa, C.
    Laetsch, T.
    Weigel, B.
    Bishop, M.
    Krystal, J.
    Levy, D.
    Mo, G.
    Wright, J.
    Dubois, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S433 - S434
  • [28] A PILOT TRIAL OF THE NOVEL CHEMOTHERAPEUTIC REGIMEN OF TOPOTECAN, IFOSFAMIDE AND CARBOPLATIN (TIC) IN CHILDREN AND ADOLESCENTS WITH REFRACTORY/RECURRENT SOLID TUMORS AND LYMPHOMAS
    Radhakrishnan, Kavita
    Lee, Alice
    Harrison, Lauren
    Morris, Erin
    Chen, Violet
    Gates, Laura
    Wells, Robert
    Wolff, Johannes
    Garvin, James
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1080 - 1080
  • [29] Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
    Meany, Holly J.
    Widemann, Brigitte C.
    Hinds, Pamela S.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Stern, Emily
    Jayaprakash, Nalini
    Peer, Cody J.
    Figg, William D.
    Hall, O. Morgan
    Sissung, Tristan M.
    Kim, Aerang
    Fox, Elizabeth
    London, Wendy B.
    Rodriguez-Galindo, Carlos
    Minturn, Jane E.
    Dome, Jeffrey S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (11)
  • [30] Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors
    Vo, Kieuhoa T.
    Karski, Erin E.
    Nasholm, Nicole M.
    Allen, Shelly
    Hollinger, Fabienne
    Gustafson, W. Clay
    Long-Boyle, Janel R.
    Shiboski, Stephen
    Matthay, Katherine K.
    DuBois, Steven G.
    ONCOTARGET, 2017, 8 (14) : 23851 - 23861
12345